Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 302

Full Length Research Paper

Tuberculosis treatment outcomes among tuberculosis/ human immunodeficiency co-infected cases treated under directly observed treatment of short course in Western Ethiopia

Eyasu Ejeta*
  • Eyasu Ejeta*
  • Departement of Medical Laboratory Sciences, College of Medical and Health Sciences, Wollega University, Nekemte, Ethiopia.
  • Search for this author on:
  • Google Scholar
Tadesse Birhanu
  • Tadesse Birhanu
  • School of Veterinary Medicine, College of Medical and Health Sciences, Wollega University, Nekemte, Ethiopia.
  • Search for this author on:
  • Google Scholar
Tsedeke Wolde
  • Tsedeke Wolde
  • Department of Public Health, College of Medical and Health Sciences, Wollega University, Nekemte, Ethiopia.
  • Search for this author on:
  • Google Scholar


  •  Received: 28 August 2014
  •  Accepted: 10 September 2014
  •  Published: 30 September 2014

Abstract

A five year (2009 to 2013) retrospective cohort study was conducted to assess the treatment outcome of tuberculosis (TB) and human immunodeficiency (HIV) co-infection patients from April to May, 2014 in six randomly selected health institutions providing Directly Observed Treatment, Short-Course (DOTS) program in Western Ethiopia. In the selected health institutions, sputum and blood samples were collected and processed using standard laboratory procedures. Bivariate and multivariate logistic regression analyses were used to assess the association between treatment outcomes and predictor variables. A total of 201 tuberculosis and human immunodeficiency co-infected patients were involved in the study: 15.9% were cured, 44.8% were treatment completed, 17.4% were died during follow-up, 10.0% were defaulted, and 11.4% transferred out to other health institutions.  The overall treatment success rates in the last five year was 60.7% and the associated predictors were antiretroviral therapy (ART) status, year of treatment, and sputum examination follow up status at second and fifth month. Therefore, actions targeting (sputum follow up and time to start ART for tuberculosis and human immunodeficiency co-infection patient) on these predictors are necessary to improve the treatment success rate.

 

Key words: Treatment outcome, HIV/TB co-infected, DOTS, Western Ethiopia.

Copyright © 2025 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 6 No. 8
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES